Literature DB >> 9040574

Blood-pressure control in the hypertensive population.

G Mancia1, R Sega, C Milesi, G Cesana, A Zanchetti.   

Abstract

BACKGROUND: In large-scale surveys of individuals with hypertension those whose clinic blood pressure is reduced to 140/90 mm Hg or less have been found to represent only a small fraction of the hypertensive population. We assessed whether these results arise because of a white-coat effect elevating clinic blood pressure.
METHODS: We randomly selected 2400 individuals from the town of Monza, Italy, and invited them to take part in our study. We measured clinic blood pressure as well as home (morning and evening measurements), and 24 h ambulatory blood pressure-ie, blood pressures largely devoid of a white-coat effect. Based on clinic blood pressure participants were then classified as normotensive, untreated hypertensive (clinic blood pressure > 140 mm Hg systolic and/or > 90 mm Hg diastolic), or treated hypertensive (having antihypertensive treatment). The mean blood pressures for each group were calculated.
FINDINGS: 1651 people took part in the study. The clinic blood pressure of treated hypertensives (n = 207; 146.9 [SD 18] mm Hg/90.2 [8.6] mm Hg) was only slightly less than in untreated hypertensives (n = 402; 148 [15.2] mm Hg/93.3 [8] mm Hg) and in both groups the blood pressure values were much greater than those of normotensive individuals (n = 1042; 119.5 [10.3] mm Hg/78.1 [6.6] mm Hg) p < 0.001. Averaged home and 24 h blood pressures were lower than clinic blood pressures but similarly higher in untreated and treated hypertensive individuals when compared with normotensive individuals. This was also the case for day and night average blood pressures. The number of treated hypertensive patients found to have blood pressures within the normal limits was small not only when based on clinic blood pressure values but also when based on ambulatory blood-pressure values.
INTERPRETATION: In the hypertensive population the number of patients with inadequate blood-pressure control is high not only when assessed in the clinic but also when assessed by ambulatory-blood-pressure monitoring or at home. The high blood-pressure values commonly found in treated hypertensive individuals cannot be accounted for by a white-coat effect but by a true lack of daily-life blood-pressure control.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9040574     DOI: 10.1016/s0140-6736(96)07099-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  37 in total

Review 1.  Current status of sustained release formulations in the treatment of hypertension. An overview.

Authors:  E Mutschler; H Knauf
Journal:  Clin Pharmacokinet       Date:  1999       Impact factor: 6.447

Review 2.  Monotherapy versus combination therapy as first line treatment of uncomplicated arterial hypertension.

Authors:  M Ruzicka; F H Leenen
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  Compliance, quality of life, and cost effectiveness.

Authors:  W B Stason
Journal:  Curr Hypertens Rep       Date:  1999-12       Impact factor: 5.369

4.  ACE inhibition and AT(1) receptor blockers: efficacy and duration in hypertension.

Authors:  P A Meredith
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

Review 5.  Epidemiology of risk factors for hypertension: implications for prevention and therapy.

Authors:  M Kornitzer; M Dramaix; G De Backer
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

6.  Prevalence, awareness, treatment, and control of hypertension: rule of thirds in the Skaraborg project.

Authors:  Ulf Lindblad; Johanna Ek; Jenny Eckner; Charlotte A Larsson; Guangliang Shan; Lennart Råstam
Journal:  Scand J Prim Health Care       Date:  2012-06       Impact factor: 2.581

Review 7.  Telmisartan: a review of its use in the management of hypertension.

Authors:  Anna J Battershill; Lesley J Scott
Journal:  Drugs       Date:  2006       Impact factor: 9.546

8.  Persistence with treatment for hypertension in actual practice.

Authors:  J J Caro; M Salas; J L Speckman; G Raggio; J D Jackson
Journal:  CMAJ       Date:  1999-01-12       Impact factor: 8.262

9.  Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data.

Authors:  J J Caro; J L Speckman; M Salas; G Raggio; J D Jackson
Journal:  CMAJ       Date:  1999-01-12       Impact factor: 8.262

10.  Pre-awakening diastolic hypotension in treated hypertensive patients: prevalence and predictors.

Authors:  K H Zheng; E H Serné; A J Kooter; Y M Smulders
Journal:  J Hum Hypertens       Date:  2015-07-23       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.